A cross-sectional study of the prevalence of cardiac valvular abnormalities in hyperprolactinemic patients treated with ergot-derived dopamine agonists
- W M Drake
- , C E Stiles
- , T A Howlett
- , A A Toogood
- , J S Bevan
- , R P Steeds
- , UK Dopamine Agonist Valvulopathy Group
- , Niki Karavitaki
Research output: Contribution to journal › Article › peer-review
38
Citations
(Scopus)